A study of Ivermectin invited the entire population of Itajaí, Brazil. In the absence of contrain indications, ivermectin was offered as an optional treatment.
This very large study found 44% lower infection and 68% lower deaths rates from twice a month usage of low dose Ivermectin.
Conclusion: In this large PSM study, regular use of ivermectin as a
prophylactic agent was associated with significantly reduced COVID-19
infection, hospitalization, and mortality rates.
This is a peer reviewed study.
Read the rest of the story HERE:
Scott Baker is a Managing Editor & The Economics Editor at Opednews, and a former blogger for Huffington Post, Daily Kos, and Global Economic Intersection.
His anthology of updated Opednews articles "America is Not Broke" was published by Tayen Lane Publishing (March, 2015) and may be found here:
Scott is a former and current President of Common Ground-NY (http://commongroundnyc.org/), a Geoist/Georgist activist group. He has written dozens of (more...)